Evidence map›Paper›PMID 36344865›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2023

The bromoporphyrins as promising anti-tumor photosensitizers in vitro.

Man-Yi Li, Le Mi, Tabbisa Namulinda, Yi-Jia Yan, Xing-Ping Zhou, Zhi-Long Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Man-Yi LiDepartment of Pharmacy, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Le MiDepartment of Pharmaceutical Science and Technology, College of Chemistry and Biology, Donghua University, Shanghai, 201620, China.
Tabbisa NamulindaDepartment of Pharmaceutical Science and Technology, College of Chemistry and Biology, Donghua University, Shanghai, 201620, China.
Yi-Jia YanDepartment of Pharmacy, Huadong Hospital, Fudan University, Shanghai, 200040, China. y_yan11@sina.com.
Xing-Ping ZhouDepartment of Pharmaceutical Science and Technology, College of Chemistry and Biology, Donghua University, Shanghai, 201620, China.
Zhi-Long ChenDepartment of Pharmacy, Huadong Hospital, Fudan University, Shanghai, 200040, China. zlchen1967@qq.com.
Donghua University · CNFudan University · CN

Funding

Foundation of Shanghai Science & Technology Committee 20430730900Foundation of Shanghai Science & Technology Committee 20490740400Foundation of Shanghai Science & Technology Committee 21430730100National Natural Science Foundation of China 21977016
6 · The paper itself

Abstract

The synthesis of ideal photosensitizers (PSs) is considered to be the most significant bottleneck in photodynamic therapy (PDT). To discover novel PSs with excellent photodynamic anti-tumor activities, a series of novel photosensitizers 5,15-diaryl-10,20-dibromoporphyrins (I

Indexed as

NeoplasmsPhotochemotherapyPorphyrinsHumansPhotosensitizing AgentsSinglet OxygenPhotosensitizing AgentsPorphyrinsSinglet OxygenAnti-tumorBromoporphyrinPhotodynamic therapyPhotosensitizer

Identifiers

PMID36344865
OpenAlexW4308552930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.